259 related articles for article (PubMed ID: 10556112)
1. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
[TBL] [Abstract][Full Text] [Related]
2. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
[TBL] [Abstract][Full Text] [Related]
3. Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
Schermuly RT; Krupnik E; Tenor H; Schudt C; Weissmann N; Rose F; Grimminger F; Seeger W; Walmrath D; Ghofrani HA
Am J Respir Crit Care Med; 2001 Nov; 164(9):1694-700. PubMed ID: 11719312
[TBL] [Abstract][Full Text] [Related]
4. Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication.
Schermuly RT; Weissmann N; Enke B; Ghofrani HA; Forssmann WG; Grimminger F; Seeger W; Walmrath D
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):219-25. PubMed ID: 11509332
[TBL] [Abstract][Full Text] [Related]
5. Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Leuchte H; Grimminger F; Seeger W; Walmrath D
Am J Physiol Lung Cell Mol Physiol; 2001 Dec; 281(6):L1361-8. PubMed ID: 11704531
[TBL] [Abstract][Full Text] [Related]
6. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F
Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
[TBL] [Abstract][Full Text] [Related]
8. Selective pulmonary vasodilation induced by aerosolized zaprinast.
Ichinose F; Adrie C; Hurford WE; Bloch KD; Zapol WM
Anesthesiology; 1998 Feb; 88(2):410-6. PubMed ID: 9477062
[TBL] [Abstract][Full Text] [Related]
9. Zardaverine and aerosolised iloprost in a model of acute respiratory failure.
Schermuly RT; Leuchte H; Ghofrani HA; Weissmann N; Rose F; Kohstall M; Olschewski H; Schudt C; Grimminger F; Seeger W; Walmrath D
Eur Respir J; 2003 Aug; 22(2):342-7. PubMed ID: 12952271
[TBL] [Abstract][Full Text] [Related]
10. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.
Haraldsson s A; Kieler-Jensen N; Ricksten SE
Anesth Analg; 2001 Dec; 93(6):1439-45, table of contents. PubMed ID: 11726420
[TBL] [Abstract][Full Text] [Related]
11. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors.
Rabe KF; Tenor H; Dent G; Schudt C; Nakashima M; Magnussen H
Am J Physiol; 1994 May; 266(5 Pt 1):L536-43. PubMed ID: 7515580
[TBL] [Abstract][Full Text] [Related]
12. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
Klein A; Zils U; Bopp C; Gries A; Martin E; Gust R
J Surg Res; 2007 Apr; 138(2):224-30. PubMed ID: 17275845
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
Welte M; Zwissler B; Habler O; Kleen M; Messmer K
Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
[TBL] [Abstract][Full Text] [Related]
15. Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation.
Sandifer BL; Brigham KL; Lawrence EC; Mottola D; Cuppels C; Parker RE
J Appl Physiol (1985); 2005 Dec; 99(6):2363-8. PubMed ID: 16141385
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension.
Ghofrani HA; Rose F; Schermuly RT; Olschewski H; Wiedemann R; Weissmann N; Schudt C; Tenor H; Seeger W; Grimminger F
Crit Care Med; 2002 Nov; 30(11):2489-92. PubMed ID: 12441759
[TBL] [Abstract][Full Text] [Related]
17. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
18. [Aerosolized and intravenous prostacyclin during one-lung ventilation. Hemodynamic and pulmonary effects].
Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S; Kuhlen R
Anaesthesist; 2004 Jul; 53(7):612-20. PubMed ID: 15085285
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary responses to selective phosphodiesterase-5 and phosphodiesterase-3 inhibitors.
Matot I; Gozal Y
Chest; 2004 Feb; 125(2):644-51. PubMed ID: 14769749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
